Top 5 Dussehra Stock Picks by Samco Securities

Samco Securities’ top stock picks –

HUL: With increased focus on premium products, several initiatives in the e-commerce market, recovery in discretionary category, premiumisation, synergy with GSK Consumer Healthcare and leverage in its digitalization capabilities, HUL is ensuring that it remains competitive, the brokerage said. are. current dynamic environment.

“It believes in consistent double-digit EPS growth in the coming decade. Given its leadership position, HUL is poised to capitalize on the long-term growth in the FMCG industry in India and we maintain a positive outlook on this.”

HDFCWith HDFC’s almost stable asset quality performance, the company has taken the market by surprise when other rivals in the housing and asset financing sectors reported a large increase in stressed loans, the brokerage said.

“HDFC is well positioned to capture a profitable market share as the demand for home loans remains consistent. With nationwide unlocking, disbursements have also picked up pace. In addition, the industry is in a sweet spot with interest rates at historic lows, strong housing demand and improving collection efficiency. Samco Securities said the stock is one of the best picks in this space.

cams: Computer Age Management Services is the market leader in a DuPoly RTA market with a share of over 70% of the total mutual fund AUM. The company has a strong and consistent financial track record of compound sales and profit growth of 8% and 13% respectively over the past 10 years.

Additionally, India has one of the lowest MF penetration globally with an AUM-GDP ratio of 12%, which is above the world average of 65%, this itself provides long-term growth potential for the overall MF and in-turn for the RTA industry . The brokerage said that CAMS since its listing has been and continues to be an attractive opportunity for investors.

Dr Lal Path Labs: Dr. Lal Path Labs is engaged in providing diagnostic and related health tests and services at national and international level. With the increase in testing volumes induced by the pandemic, companies’ continued focus on service parameters and timely changes have helped in achieving resilient growth.

“With the diagnostics industry poised for growth, we believe that premium and organized players such as Dr. Lal Path Labs are poised to capture market share and thus make for an attractive investment bet,” said Samco.

Affle (India)Effle is a leading edtech company with a proprietary consumer intelligence platform that helps its clients improve user acquisition and user engagement through contextual mobile advertising.

The company’s management expects the operating margins to be sustainable in the coming quarters and aims to deliver at least 25-30% revenue CAGR in the medium term. Samco said it remains positive given its strong balance sheet, positive cash flow conversion, increased usage of the platform and long growth runway.

The views and recommendations given above are those of individual analysts or broking companies and not of Mint.